Roger N. Farah - Nov 30, 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
Director
Signature
/s/ Roger N. Farah
Stock symbol
CVS
Transactions as of
Nov 30, 2024
Transactions value $
$2,999,981
Form type
4
Date filed
12/3/2024, 05:18 PM
Previous filing
Oct 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock (Restricted) Award $3M +50.1K $59.85 50.1K Nov 30, 2024 Direct F1
holding CVS Common Stock 4.12K Nov 30, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Share Credits 36.4K Nov 30, 2024 Common Stock 36.4K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in two equal installments, commencing 11/30/2025.
F2 Consists of deferred stock units, each to be converted into one share of common stock and issued pursuant to the Reporting Person's election.